SSTR5 (somatostatin receptor 5)

2003-02-01  

Identity

HGNC
LOCATION
16p13.3
LOCUSID
ALIAS
SS-5-R
FUSION GENES

Other Information

Locus ID:

NCBI: 6755
MIM: 182455
HGNC: 11334
Ensembl: ENSG00000162009

Variants:

dbSNP: 6755
ClinVar: 6755
TCGA: ENSG00000162009
COSMIC: SSTR5

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000162009ENST00000293897P35346

Expression (GTEx)

0
5
10
15

Pathways

PathwaySourceExternal ID
Neuroactive ligand-receptor interactionKEGGko04080
Neuroactive ligand-receptor interactionKEGGhsa04080
cAMP signaling pathwayKEGGhsa04024
cAMP signaling pathwayKEGGko04024
Signal TransductionREACTOMER-HSA-162582
Signaling by GPCRREACTOMER-HSA-372790
GPCR ligand bindingREACTOMER-HSA-500792
Class A/1 (Rhodopsin-like receptors)REACTOMER-HSA-373076
Peptide ligand-binding receptorsREACTOMER-HSA-375276
GPCR downstream signalingREACTOMER-HSA-388396
G alpha (i) signalling eventsREACTOMER-HSA-418594

References

Pubmed IDYearTitleCitations
346017902022Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST(5) ) in pituitary and pancreatic neuroendocrine tumors.6
351630672022Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance.5
346017902022Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SST(5) ) in pituitary and pancreatic neuroendocrine tumors.6
351630672022Somatostatin Receptor Splicing Variant sst5TMD4 Overexpression in Glioblastoma Is Associated with Poor Survival, Increased Aggressiveness Features, and Somatostatin Analogs Resistance.5
334289652021Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.5
334912862021Predictive and prognostic significance of tumour subtype, SSTR1-5 and e-cadherin expression in a well-defined cohort of patients with acromegaly.6
342248032021Somatostatin receptor 5 is critical for protecting intestinal barrier function in vivo and in vitro.6
334289652021Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.5
334912862021Predictive and prognostic significance of tumour subtype, SSTR1-5 and e-cadherin expression in a well-defined cohort of patients with acromegaly.6
342248032021Somatostatin receptor 5 is critical for protecting intestinal barrier function in vivo and in vitro.6
302828212018Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.5
302828212018Somatostatin receptor subtype 5 modifies hypothalamic-pituitary-adrenal axis stress function.5
279841802017Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1.7
287058092017The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer.25
279841802017Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1.7

Citation

Dessen P

SSTR5 (somatostatin receptor 5)

Atlas Genet Cytogenet Oncol Haematol. 2003-02-01

Online version: http://atlasgeneticsoncology.org/gene/42405/sstr5